Literature DB >> 19628404

UV radiation and skin cancer in Norway.

I Medhaug1, J A Olseth, J Reuder.   

Abstract

A distinct increase in skin cancer incidences is observed since the registration started in Norway in the 1950s. As UV radiation is assumed to be the main risk factor for skin cancer, hourly values of the UV irradiance were reconstructed for the period 1957-2005 for 17 of the Norwegian counties (58-70 degrees N). For reconstruction, a radiation transfer model is run with total ozone amount and cloud information as meteorological input. Reconstructed hourly erythemally weighted UV irradiances for about 5 years are compared to measurements at four stations, two stations representing the north-south extension of Norway, and two stations at about 60 degrees N representing the eastern inland - Western coastal contrasts. The agreement between reconstructed and measured UV varies between 0% for the northernmost site to 10-15% overestimation for the other locations. For clear sky, a reasonable agreement between reconstructed and measured data was found for all stations, while for overcast, an overestimation of 10-20% was found for all but the northernmost station. Both the cancer incidences and the reconstructed UV values have a distinct north-south increase. The UV increase towards south is mostly due to increasing solar elevation. The west to east increase is much smaller, and differences in UV are due to differences in both cloud optical thickness and total cloud amount. One additional outcome from this work is that long-term UV-data are reconstructed for Norway, data that can be used in further biological and medical studies related to UV effects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19628404     DOI: 10.1016/j.jphotobiol.2009.06.011

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  8 in total

1.  Cyclooxygenase-2 (COX-2) mediates arsenite inhibition of UVB-induced cellular apoptosis in mouse epidermal Cl41 cells.

Authors:  Z Zuo; W Ouyang; J Li; M Costa; C Huang
Journal:  Curr Cancer Drug Targets       Date:  2012-07       Impact factor: 3.428

2.  Cutaneous squamous cell carcinoma in Norway 1963-2011: increasing incidence and stable mortality.

Authors:  Trude E Robsahm; Per Helsing; Marit B Veierød
Journal:  Cancer Med       Date:  2015-01-26       Impact factor: 4.452

3.  Temporal and spatial melanoma trends in Austria: an ecological study.

Authors:  Daniela Haluza; Stana Simic; Hanns Moshammer
Journal:  Int J Environ Res Public Health       Date:  2014-01-06       Impact factor: 3.390

4.  A protocol for prospective studies of 25-hydroxyvitamin D, leptin and body mass index in relation to cutaneous melanoma incidence and survival.

Authors:  Jo Steinson Stenehjem; Tom K Grimsrud; Judith R Rees; Linda Vos; Ronnie Babigumira; Marit B Veierød; Trude Eid Robsahm
Journal:  BMJ Open       Date:  2017-06-21       Impact factor: 2.692

Review 5.  Air pollution, UV irradiation and skin carcinogenesis: what we know, where we stand and what is likely to happen in the future?

Authors:  Barbara Zegarska; Katarzyna Pietkun; Wojciech Zegarski; Paulina Bolibok; Marek Wiśniewski; Katarzyna Roszek; Joanna Czarnecka; Maciej Nowacki
Journal:  Postepy Dermatol Alergol       Date:  2017-02-07       Impact factor: 1.837

6.  Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study.

Authors:  Leon Alexander Mclaren Berge; Bettina Kulle Andreassen; Jo Steinson Stenehjem; Trond Heir; Øystein Karlstad; Asta Juzeniene; Reza Ghiasvand; Inger Kristin Larsen; Adele C Green; Marit Bragelien Veierød; Trude Eid Robsahm
Journal:  Clin Epidemiol       Date:  2020-12-18       Impact factor: 4.790

7.  Use of Antidepressants and Risk of Cutaneous Melanoma: A Prospective Registry-Based Case-Control Study.

Authors:  Leon Alexander Mclaren Berge; Bettina Kulle Andreassen; Jo S Stenehjem; Trond Heir; Kari Furu; Asta Juzeniene; Ingrid Roscher; Inger Kristin Larsen; Adele C Green; Marit B Veierød; Trude E Robsahm
Journal:  Clin Epidemiol       Date:  2020-02-21       Impact factor: 4.790

8.  Prediagnostic serum 25-hydroxyvitamin D and melanoma risk.

Authors:  Jo S Stenehjem; Nathalie C Støer; Reza Ghiasvand; Tom K Grimsrud; Ronnie Babigumira; Judy R Rees; Lill Tove Nilsen; Bjørn Johnsen; Per M Thorsby; Marit B Veierød; Trude E Robsahm
Journal:  Sci Rep       Date:  2020-11-18       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.